Document is current
Any future updates will be listed below
-
Authors
Prossin, Alan https://orcid.org/0000-0003-1262-522X
Koch, Alisa
Campbell, Phillip
Laumet, Geoffroy https://orcid.org/0000-0001-6752-3592
Stohler, Christian S.
Dantzer, Robert
Zubieta, Jon-Kar
- License Information
-
More Information
Article History
Received: 8 March 2021
Revised: 5 October 2021
Accepted: 14 October 2021
First Online: 29 October 2021
Competing interests
: Dr. Koch has consulted for Metastatix, Pennside Partners, Cypress Bioscience, Takeda Pharmaceuticals, NiCox SA, and Celtaxsys and has been an expert for Kirkland and Ellis. Dr. Koch was a consultant for Gerson Lehrman Group of Healthcare and Biomedical Advisors, Guidepoint Global, UCB Pharmaceuticals, and the Fund for Autoimmune Research. Dr. Koch has received investigator-initiated research grants for Bristol-Myers Squibb, Roche, and Takeda Pharmaceuticals. Dr. Koch is currently employed by Eli Lilly and Company. All other authors report no biomedical financial or potential conflicts of interest.
